Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kathleen Corey, M.D.

Co-Author

This page shows the publications co-authored by Kathleen Corey and Zoe Memel.
Connection Strength

2.480
  1. Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence? Clin Liver Dis (Hoboken). 2022 Mar; 19(3):101-105.
    View in: PubMed
    Score: 0.985
  2. Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis. JAMA. 2021 11 23; 326(20):2015-2017.
    View in: PubMed
    Score: 0.971
  3. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2022 02; 6(2):309-319.
    View in: PubMed
    Score: 0.239
  4. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Hepatol Commun. 2021 01; 5(1):133-143.
    View in: PubMed
    Score: 0.226
  5. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis. Metabolism. 2021 07; 120:154780.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.